Glucagon-like peptide-1 is a significant development in our management field. Originally intended to address diabetes , its drugs have shown a substantial capacity to encourage weight reduction and improve overall health . Researchers increasingly exploring their potential in managing being overweight in individuals without a diabetes diagnosis. G